title: Acetylcholine receptor antibodies as a marker of treatable fatigue in HIV-1 infected individuals.
authors: Neuromuscular Diseases Section, National Institute of Neurologic Disorders and Stroke, NIH, Bethesda, Maryland 20892-1382, USA.
authors: E J
authors: EJ
authors: Cupler
authors: C
authors: C
authors: Otero
authors: K
authors: K
authors: Hench
authors: C
authors: C
authors: Luciano
authors: M C
authors: MC
authors: Dalakas
mesh_terms: D000328:Adult; D000906:Antibodies / Q000032:analysis*; D015415:Biomarkers; D005221:Fatigue / Q000150:complications / Q000188:drug therapy* / Q000276:immunology*; D015658:HIV Infections / Q000150:complications*; D015497:HIV-1; D006801:Humans; D008297:Male; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D011950:Receptors, Cholinergic / Q000276:immunology*
chemical_list: D000906:Antibodies; D015415:Biomarkers; D011950:Receptors, Cholinergic; D011729:Pyridostigmine Bromide